Skip to main content
. 2018 Nov 13;8:16767. doi: 10.1038/s41598-018-35175-z

Table 3.

Results of laboratory tests before and after medication use according to medication treatment groups.

Total N No treatment With treatment
Mean/n SD/Row/% Mean/n SD/Row%
Creatinine (mg/dL)
  allopurinol or febuxostat 762 1.81 2.01 1.84 2.18
  allopurinol or febuxostat plus fenofibrate 68 1.21 0.29 1.26 0.27
BUN (mg/dL)
  allopurinol or febuxostat 760 22.23 17.22 23.07 18.6
  allopurinol or febuxostat plus fenofibrate 68 15.54 8.04 15.24 5.07
AST (IU/L)
  allopurinol or febuxostat 760 28.89 22.33 30.15 21.31
  allopurinol or febuxostat plus fenofibrate 69 33.58 22.14 33.09 17.6
ALT (U/L)
  allopurinol or febuxostat 759 35.79 44.0 35.72 30.15
  allopurinol or febuxostat plus fenofibrate 67 46.16 39.86 40.09 27.23
AST*
  allopurinol or febuxostat 698 11 1.6 16 2.3
  allopurinol or febuxostat plus fenofibrate 67 3 4.5 1 1.5
ALT*
  allopurinol or febuxostat 698 26 3.7 31 4.4
  allopurinol or febuxostat plus fenofibrate 67 6 9.0 3 4.5
Bilirubin
  allopurinol or febuxostat 755 0.73 0.37 0.76 0.41
  allopurinol or febuxostat plus fenofibrate 68 0.71 0.35 0.68 0.25
Total cholesterol
  allopurinol or febuxostat 758 181.0 42.0 180.96 39.83
  allopurinol or febuxostat plus fenofibrate 68 203.2 43.7 190.81 38.15
HDL cholesterol
  allopurinol or febuxostat 430 42.91 12.18 42.91 12.18
  allopurinol or febuxostat plus fenofibrate 56 39.13 9.99 39.13 9.99
LDL cholesterol
  allopurinol or febuxostat 187 113.71 38.41 109.49 34.26
  allopurinol or febuxostat plus fenofibrate 23 120.04 39.71 102.27 42.5
Triglyceride
  allopurinol or febuxostat 469 196.41 106.76 187.71 109.39
  allopurinol or febuxostat plus fenofibrate 62 418.42 190.01 316.17 185.15
Glucose
  allopurinol or febuxostat 754 110.41 33.86 106.55 28.27
  allopurinol or febuxostat plus fenofibrate 68 106.68 27.09 105.39 27.03

SD: standard deviation; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; HDL: high density lipoprotein; LDL: low density lipoprotein.

*The number and proportion of patients who exceed three times of the maximum normal range before and after medication.